Ingredion Incorporated, produces and sells starches and sweeteners for various industries. The company is headquartered in Westchester, Illinois.
| Revenue (TTM) | $7.19B |
| Gross Profit (TTM) | $1.66B |
| EBITDA | $1.09B |
| Operating Margin | 10.40% |
| Return on Equity | 12.90% |
| Return on Assets | 6.78% |
| Revenue/Share (TTM) | $113.60 |
| Book Value | $72.97 |
| Price-to-Book | 1.34 |
| Price-to-Sales (TTM) | 0.80 |
| EV/Revenue | 0.967 |
| EV/EBITDA | 6.22 |
| Quarterly Earnings Growth (YoY) | -14.60% |
| Quarterly Revenue Growth (YoY) | -1.30% |
| Shares Outstanding | $63.06M |
| Float | $61.92M |
| % Insiders | 0.91% |
| % Institutions | 103.13% |
Volatility is currently expanding
Ingredion's Q3 earnings lag estimates as higher manufacturing costs and softer demand squeeze margins, prompting a cut to its 2026 earnings outlook.
Ingredion (INGR) came out with quarterly earnings of $2.28 per share, missing the Zacks Consensus Estimate of $2.55 per share. This compares to earnings of $2.75 per share a year ago.
T&HS delivered its 10th consecutive quarter of net sales volume growth, with share gains in strategic categories, including continued clean label growth globally Third quarter 2026 reported and adjusted* operating income both decreased 19% compared to the third quarter 2025 Third quarter 2026 reported and adjusted diluted EPS were $2.23 and $2.28, compared with $2.61 and $2.75 in the third quarter 2025 Adjusting full-year guidance for reported diluted EPS to be in the range of $8.04 to $8.49 and adjusted diluted EPS to be in the range of $9.25 to $9.70 WESTCHESTER, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its third quarter 2026 results.
Ingredion's Q3 earnings are likely to have faced pressure from its Pakistan divestiture, currency headwinds and higher costs, while specialty ingredient demand may have offered some support.
ADM and INGR pursue growth through distinct strategies, with differences in earnings momentum, operational performance, valuation and market positioning.
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingredion remains a Buy, with strong long-term growth potential driven by its shift toward higher-margin specialty ingredients and functional beverages. The proposed $5B Tate & Lyle acquisition offers transformative synergies, and rapid >15% Adj. EPS accretion potential, and geographic diversification, with $130M run-rate synergies identified by 2030. INGR's resilient business model, private-label exposure, and normalization at Argo support stable cash flows and a well-covered, growing dividend.
Ingredion's productivity initiatives, manufacturing improvements and cost discipline drive efficiency gains and support operational resilience despite persistent inflationary pressures.
WESTCHESTER, Ill., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its third quarter 2026 financial results for the period ended September 30, 2026, before the market opens Thursday, November 5, 2026.
TRMB, INGR and DE offer exposure to precision agriculture, food innovation and smarter farming technologies shaping the AgTech landscape.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on INGR and any ticker you trade — then tracks every position and per-strategy win rate.
